Operating profit before deduction of amortization: ADMA Biologics, Inc. (ADMA)
ADMA Biologics is modernizing its plasma fractionation methods to produce unique immunoglobulins. Business development relies on partnerships with hospitals and transfusion centers. The EBITDA level confirms the efficiency of this model, where 242.78 expresses the metric's value today. The company's strategy is based on full control of supply chains and the expansion of immunodeficiency therapies.
ADMA Biologics, Inc. (ADMA) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio ADMA Biologics|ADMA - Long-Term Debt to Capital|Current Liabilities to Capital ADMA Biologics Inc|ADMA - Company Aggregate Debts|Debts to Book Capitalization ADMA Biologics|ADMA - Company Long-Term Debts|Company Short-Term Indebtedness ADMA Biologics|Quick Liquidity Indicator admabiologics.com
- earnings and multiples data:
ADMA - Net Profit|Projected Future Earnings ADMA Biologics|ADMA - Price to Earnings Ratio|Future Price to Earnings Multiple admabiologics.com|ADMA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ADMA Biologics|ADMA - Operating profit EBITDA|Net earnings per share for the last four quarters ADMA Biologics|ADMA - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months admabiologics.com|ADMA - Earnings per share growth in current year|Net earnings per share growth forecast for next year ADMA Biologics
Summary company analytics:ADMA (ADMA Corp)
For ADMA Biologics, which controls the full production cycle of plasma-derived medicines, this metric reflects the actual cash flow from core operations before tax payments. By analyzing the company's EBITDA, an investor excludes accounting adjustments to assess the biopharmaceutical business's ability to generate liquidity for scaling within the immunology segment and covering operating expenses.
Who ADMA Biologics competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|Protagonist (PTGX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Immunovant Inc|Operating profit before deduction of amortization KNSA|Operating profit EBITDA Grifols Biemat|Profit before payment of interest, taxes and amortization Adaptive Biotechnologies (ADPT)|celldex.com - Operating profit before amortization|Operating profit EBITDA AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Profit before interest, taxes and amortization|Vera Pharma - Operating profit EBITDA|DNTH - Operating profit EBITDA|PHVS: Operating profit EBITDA|Operating profit before amortization ABCL|Profit before payment of interest, taxes and amortization Tourmaline Bio|Operating profit before deduction of amortization Precigen Inc (PGEN)|Operating profit EBITDA PHAR|Operating profit EBITDA Nektar Corp (NKTR)|Upstream Bio Inc - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ZBIO|Immunome - Operating profit EBITDA|GOSS: Profit before payment of interest, taxes and amortization|KALV: Operating profit EBITDA|SEPN - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Pieris Pharmaceuticals|Profit before interest, taxes and amortization savarapharma.com SVRA|Profit before payment of interest, taxes and amortization Rigel Pharmaceuticals, Inc. (RIGL)|Profit before payment of interest, taxes and amortization ANAB (AnaptysBio Inc)|Profit before payment of interest, taxes and amortization Astria Pharma ATXS|enGene Corp (ENGN) - Profit before interest, taxes and amortization|RAPT Therapeutics - Operating profit EBITDA|Operating profit before depreciation charges Aerovate Therapeutics Inc (JBIO)|ACRS: Operating profit EBITDA|KYTX - Operating income before deduction of amortization|TLSA (Tiziana Life Sciences PLC) - Operating profit EBITDA|Operating profit before deduction of amortization Cabaletta Bio Inc (CABA)|Profit before payment of interest, taxes and amortization Ventyx Biosciences (VTYX)|Operating income before deduction of amortization theratech.com|Operating profit EBITDA AVTX (Avalo Therapeutics)|Operating profit EBITDA Eledon Pharmaceuticals Inc. ELDN|Agenus Inc - Operating profit EBITDA|CLYM (Climb Bio, Inc) - Operating profit before amortization|Zura Bio (ZURA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atyrpharma.com|ADAG (Adagene Inc) - Operating profit EBITDA|Operating profit EBITDA Ikena Oncology, Inc.|Profit before payment of interest, taxes and amortization Shattuck Labs, Inc. (STTK)|EQ: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CNTB (Connect Biopharma Holdings Limited)|Income before deduction of interest, taxes and amortization IMUX|Atara Biotherapeutics Inc - Operating profit EBITDA|IFRX - Operating profit EBITDA|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|Adicet Bio, Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Celularity Inc|Operating profit before deduction of amortization inmunebio.com (INMB)|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc. (KZR)|SAB Biotherapeutics, Inc - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AKTX|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|Operating income before deduction of amortization Q32 Bio Inc. QTTB|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Edesa Biotech Inc|Profit before payment of interest, taxes and amortization iBio Corp|Operating profit before deduction of amortization Carisma Tx (CARM)|Operating profit before deduction of amortization XTLB (XTL Biopharmaceuticals)|Operating profit EBITDA boltbio.com (BOLT)|Profit before payment of interest, taxes and amortization HCW Biologics HCWB|APVO: Operating profit before amortization|AIM ImmunoTech Inc. - Operating profit EBITDA|Profit before interest, taxes and amortization Aditxt|GRI: Operating profit EBITDA|xortx.com (XRTX) - Operating profit EBITDA|HIND (Vyome Holdings) - Operating profit EBITDA|Operating profit before amortization REVB (Revelation Biosciences Inc)|Profit before payment of interest, taxes and amortization Indaptus (INDP)|Operating profit before deduction of amortization BiondVax Pharmaceuticals SCNI|Operating profit EBITDA CALI (CalciMedica)|Operating profit EBITDA Affimed NV AFMD|ALLK: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization HOOK (HOOKIPA Pharma Inc.)|IGMS: Operating profit EBITDA|ITOS (iTeos Pharma) - Profit before payment of interest, taxes and amortization|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|tcbiopharm.com (TCBP) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
